Article

Apotex Recalls Glass-Containing Lot of Nasal Spray

Author(s):

The fluticasone propionate nasal spray is indicated for treatment of seasonal and perennial allergic rhinitis, as well as the management of sinus pain and pressure associated with pediatric rhinitis.

nasal spray, recall, glass, fda

Apotex Corporation has announced a voluntary recall of 1 lot of fluticasone propionate nasal spray after it was found to have small glass particles in it.

The 120 metered 50-mcg nasal spray products were found to contain glass, which could block the actuator and impact the pump’s functionality. The therapy is indicated for the treatment of seasonal and perennial allergic rhinitis, as well as the management of sinus pain and pressure associated with rhinitis in patients aged 4-17 years old.

The issue that drove the recall was initially discovered through a customer complaint, according to the US Food and Drug Administration (FDA). The product is a nationwide-distributed therapy.

Apotex has already notified wholesalers and distributors via a recall letter, in order to arrange returns of affected products. The FDA advises consumers and institutiosn with any existing inventory of the lot subject to the recall to stop use and distribution of remaining units, and to quarantine the products immediately. Health care providers in organizations should be informed, as should any accounts or additional locations who may have received the product for retail purposes.

Reports adverse reactions or quality problems experienced with the use of the product can be directed to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail, or by fax.

Related Videos
How to Manage Aspirin-Exacerbated Respiratory Disease
Safety Data on Dupilumab, Ensifentrine for COPD, with MeiLan Han, MD
MeiLan Han, MD: Discussing Updates on Dupilumab, Ensifentrine in 2025 GOLD Report
Physician, Patient, and Partner Perspectives on AERD with Mitchell Grayson, MD, Rhonda Nelson, and Wayne Nelson
Monica Kraft, MD: Discussing Phase 3b Findings on Albuterol/Budesonide for Asthma
How Artificial Intelligence is Being Used in Lung Imaging, with Rachel Eddy, PhD
Developing Risk Assessment Tools for Viruses in School
Using Microbiomes to Diagnose Ventilator-Associated Pneumonia
What Do Patients Need to Learn About their Hypersensitivity Pneumonitis?
© 2024 MJH Life Sciences

All rights reserved.